KR910007540A - 혈구 감소 장해의 예방ㆍ치료제 - Google Patents

혈구 감소 장해의 예방ㆍ치료제 Download PDF

Info

Publication number
KR910007540A
KR910007540A KR1019900015403A KR900015403A KR910007540A KR 910007540 A KR910007540 A KR 910007540A KR 1019900015403 A KR1019900015403 A KR 1019900015403A KR 900015403 A KR900015403 A KR 900015403A KR 910007540 A KR910007540 A KR 910007540A
Authority
KR
South Korea
Prior art keywords
prevention
treatment
blood cell
cell reduction
gly
Prior art date
Application number
KR1019900015403A
Other languages
English (en)
Other versions
KR930001304B1 (ko
Inventor
아키라 아와야
히사시 고바야시
하야오 아베
Original Assignee
미시마 마사요시
미쓰이 도오아쓰 카가쿠 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미시마 마사요시, 미쓰이 도오아쓰 카가쿠 가부시끼가이샤 filed Critical 미시마 마사요시
Publication of KR910007540A publication Critical patent/KR910007540A/ko
Application granted granted Critical
Publication of KR930001304B1 publication Critical patent/KR930001304B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids

Abstract

내용 없음.

Description

혈구 감소 장해의 예방·치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 하기의 아미노산 배열
    pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn
    을 가진 노나펩티드 또는, 그 C말단의 아스파라긴의 카르복실기에서의 에스테르, 아미드 또는, 그들 각 화합물의 약학적으로 허용할수 있는 염 또는 그 각 화합물과 금속과의 결합물을 유효성분으로서 함유하는 것을 특징으로 하는 각종 혈구의 감소 장애의 예방·치료제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900015403A 1989-10-04 1990-09-27 혈구 감소 장해의 예방·치료제 KR930001304B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1-257729 1989-10-04
JP25772989 1989-10-04
JP257729 1989-10-04

Publications (2)

Publication Number Publication Date
KR910007540A true KR910007540A (ko) 1991-05-30
KR930001304B1 KR930001304B1 (ko) 1993-02-25

Family

ID=17310285

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900015403A KR930001304B1 (ko) 1989-10-04 1990-09-27 혈구 감소 장해의 예방·치료제

Country Status (3)

Country Link
EP (1) EP0425828A3 (ko)
KR (1) KR930001304B1 (ko)
CA (1) CA2026306A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2962335B1 (fr) 2010-07-12 2013-01-18 Cll Pharma Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives
US9468662B2 (en) 2010-07-12 2016-10-18 Orphit Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572889A (en) * 1977-05-25 1980-08-06 Inst Nat Sante Rech Med Polypeptides
JPS54148722A (en) * 1978-05-12 1979-11-21 Takeda Chem Ind Ltd Nonapeptide and its preparation
KR920002700B1 (ko) * 1988-04-04 1992-03-31 미쓰이 도오아쓰 카가쿠 가부시끼가이샤 방사선 장해 방호제(防護劑)

Also Published As

Publication number Publication date
EP0425828A2 (en) 1991-05-08
CA2026306A1 (en) 1991-04-05
KR930001304B1 (ko) 1993-02-25
EP0425828A3 (en) 1991-09-18

Similar Documents

Publication Publication Date Title
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
ATE50493T1 (de) Ibuprofen enthaltendes arzneimittel.
CA2029524A1 (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
GT199800126A (es) Terapia de combinacion.
KR870005637A (ko) 약물 데포
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
KR850007208A (ko) 약산성욕 염조성물
FI875272A (fi) Baerarloesningsmedelssystem i tvao fas.
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
KR890004680A (ko) 좌 약
IT8820048A0 (it) Telestampa presso un utente sistema e apparecchiatura di telefonico di informazione provenienti da enti di pubblica utilita', o simili, conpossibilita' di interazione e suoi metodi di realizzazione e di utilizzazione.
RU94002133A (ru) 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство
DK0498144T3 (da) Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
ES2171444T3 (es) Una solucion intravenosa que disminuye las perdidas de proteinas y de agua corporales.
KR950032272A (ko) L-리실-글리실-l-히스티딘 및 이를 함유하는 창상 유합용 치료제
KR920703050A (ko) 골형성 촉진제
KR910007540A (ko) 혈구 감소 장해의 예방ㆍ치료제
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
KR910009267A (ko) 우울증의 치료방법
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
KR970061248A (ko) 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체
DK0437225T3 (da) Topiske præparater
RS49520B (sr) Antimikrobno aktivne smeše
FR2684552B1 (fr) Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants.
DE69208681T2 (de) Verwendungen von 1,1,1,3,3,3-hexafluoropropan

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee